Contrast-enhanced mammography (CEM) has emerged as a viable alternative to contrast-
enhanced breast MRI, and it may increase access to vascular imaging while reducing …

Background It has been proposed that magnetic resonance imaging (MRI) be used to guide
breast cancer surgery by differentiating residual tumor from pathologic complete response …

The use of breast magnetic resonance imaging (MRI) is rapidly increasing. EUSOMA
organised a workshop in Milan on 20–21st October 2008 to evaluate the evidence currently …

Purpose To evaluate volumetric magnetic resonance (MR) imaging for predicting recurrence-
free survival (RFS) after neoadjuvant chemotherapy (NACT) of breast cancer and to …

Inflammatory breast cancer (IBC) is a rare and aggressive form of invasive breast cancer
accounting for 2.5% of all breast cancer cases. It is characterized by rapid progression, local …

Background Neoadjuvant chemotherapy for early breast cancer can avoid mastectomy by
shrinkage of tumour volume. This review assesses the effectiveness of neoadjuvant …

Contrast-enhanced mammography (CEM) combines conventional mammography with
iodinated contrast material to improve cancer detection. CEM has comparable performance …

Early randomized trials of the addition of neoadjuvant chemotherapy (NACT) to the
treatment regimen of patients with breast cancer failed to demonstrate an improvement in …

Magnetic resonance (MR) imaging is emerging as the most sensitive modality that is
currently available for the detection of primary or recurrent breast cancer. Although this …

Contrast-enhanced mammography (CEM) is a develo** modality used for the workup and
management of breast cancer. Although diagnostic imaging modalities such as …